Locally advanced non-metastatic pancreatic cancer - Can we do more?

被引：2

作者：

Hawkins, M. A. ^{[1
]}

Tait, D. ^{[1
]}

机构：

[1] Royal Marsden Fdn NHS Trust, Dept Clin Oncol, Sutton SM2 5PT, Surrey, England

来源：

CLINICAL ONCOLOGY | 2008年 / 20卷 / 07期

关键词：

D O I：

10.1016/j.clon.2008.04.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：532 / 534

页数：3

共 21 条

[1] Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer [J].

Blackstock, AW ;

Bernard, SA ;

Richards, F ;

Eagle, KS ;

Case, LD ;

Poole, ME ;

Savage, PD ;

Tepper, JE .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2208-2212

[2] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[3]

De Vita V.T., 2004, CANC PRINCIPLES PRAC, V7th

[4]

DOUGLASS HO, 1988, JNCI-J NATL CANCER I, V80, P751

[5] Resected adenocarcinoma of the pancreas—616 patients: Results, outcomes, and prognostic indicators [J].

John Jorgensen .

Journal of Gastrointestinal Surgery, 2001, 5 (6) :681-681

[6]

Kindler HL, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.12.0949

[7] Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer [J].

Krzyzanowska, Monika K. ;

Earle, Craig C. ;

Kuntz, Karen M. ;

Weeks, Jane C. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01) :211-218

[8] Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate [J].

Lima, CMR ;

Green, MR ;

Rotche, R ;

Miller, WH ;

Jeffrey, GM ;

Cisar, LA ;

Morganti, A ;

Orlando, N ;

Gruia, G ;

Miller, LL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3776-3783

[9] Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial [J].

Louvet, C ;

Labianca, R ;

Hammel, P ;

Lledo, G ;

Zampino, MG ;

André, T ;

Zaniboni, A ;

Ducreux, M ;

Aitini, E ;

Taïeb, J ;

Faroux, R ;

Lepere, C ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3509-3516

[10]

MOERTEL CG, 1981, CANCER, V48, P1705, DOI 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO

← 1 2 3 →